Efficacy and safety of palbociclib and ribociclib in patients with estrogen and/or progesterone receptor positive, HER2 receptor negative metastatic breast cancer in routine clinical practice.

Efficacy and safety of palbociclib and ribociclib in patients with estrogen and/or progesterone receptor positive, HER2 receptor negative metastatic breast cancer in routine clinical practice.

<h4>Background</h4>There is scant data from India on efficacy and safety of palbociclib and ribociclib in routine clinical practice.<h4>Methods</h4>This retrospective, observational, single institution study included patients with estrogen and/or progesterone receptor positiv...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sushmita Rath, Prahalad Elamarthi, Pallavi Parab, Seema Gulia, Ravindra Nandhana, Smruti Mokal, Yogesh Kembhavi, Prema Perumal, Jyoti Bajpai, Jaya Ghosh, Sudeep Gupta
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/4e01cb73ac5f4ba695434e6fa2625692
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares